Development of a Sensitive and Rapid HPLC-MS Method for Dihydrocodeine and Dihydromorphine: Application to Bioequivalence Studies

J Chromatogr Sci. 2022 Dec 13;60(10):977-983. doi: 10.1093/chromsci/bmac052.

Abstract

A ultraperformance liquid chromatography-tandem mass spectrometry method has been developed to determine dihydrocodeine (DHC) and dihydromorphine (DHM) in human plasma using dihydrocodeine-d6 and desomorphine as internal standards (IS). Acetonitrile-water-ammonium format was used as the mobile phase, in gradient elution on a C18 column. The concentration of DHC and DHM was determined in the positive ionization mode of mass spectrometry. The total chromatogram run time was 3.2 min, and the linear ranges of DHC and DHM were 1.000-400.0 ng/mL and 0.050-20.00 ng/mL, respectively. The method was fully validated concerning precision, accuracy, selectivity, linearity, recovery, stability and matrix effect. The method had been successfully applied to the bioequivalence test. In addition, we found that a high-fat diet impacts the Tmax and t1/2 of DHC.

MeSH terms

  • Chromatography, High Pressure Liquid / methods
  • Dihydromorphine
  • Humans
  • Reproducibility of Results
  • Tandem Mass Spectrometry* / methods
  • Therapeutic Equivalency

Substances

  • dihydrocodeine
  • Dihydromorphine